KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Moderna (MRNA) Enterprise Value: 2016-2025

Historic Enterprise Value for Moderna (MRNA) over the last 8 years, with Sep 2025 value amounting to $5.5 billion.

  • Moderna's Enterprise Value fell 70.54% to $5.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.6 billion, marking a year-over-year decrease of 85.27%. This contributed to the annual value of $9.0 billion for FY2024, which is 69.38% down from last year.
  • Moderna's Enterprise Value amounted to $5.5 billion in Q3 2025, which was up 0.12% from $5.5 billion recorded in Q2 2025.
  • Moderna's Enterprise Value's 5-year high stood at $146.4 billion during Q3 2021, with a 5-year trough of $5.0 billion in Q1 2025.
  • Its 3-year average for Enterprise Value is $23.9 billion, with a median of $29.3 billion in 2023.
  • Per our database at Business Quant, Moderna's Enterprise Value soared by 494.32% in 2021 and then tumbled by 85.04% in 2025.
  • Over the past 5 years, Moderna's Enterprise Value (Quarterly) stood at $92.2 billion in 2021, then tumbled by 35.93% to $59.1 billion in 2022, then crashed by 50.40% to $29.3 billion in 2023, then plummeted by 69.38% to $9.0 billion in 2024, then tumbled by 70.54% to $5.5 billion in 2025.
  • Its Enterprise Value was $5.5 billion in Q3 2025, compared to $5.5 billion in Q2 2025 and $5.0 billion in Q1 2025.